Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience (NCT03724331) | Clinical Trial Compass
CompletedNot Applicable
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
United States235 participantsStarted 2019-06-04
Plain-language summary
Among 13 core symptoms across 3,106 breast, colorectal, prostate, and lung cancer patients, persons with lung cancer were the most symptomatic, with moderate to severe fatigue being reported with the greatest prevalence. This is a proposed randomized controlled trial of a novel rehabilitative intervention for persons with non-small cell lung cancer after surgery that promotes self-management of cancer-related fatigue (CRF) and is practical, portable, low cost, and safe. The results of the study will provide a novel exercise intervention, and its optimal timing, that helps a vulnerable population by reducing CRF severity and fatigability and is applicable to nearly all post-thoracotomy lung cancer patients.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women and men
* At least 18 years of age (Michigan) and 19 years of age in (Nebraska)
* With suspected non-small cell lung cancer to be confirmed after surgery
* Karnofsky Performance Status score of at least 70%
* Thoracic surgeon approval pre- and post-surgery
* Medically stable comorbid conditions allowing for non-small cell lung cancer surgery clearance
* Has phone access capability
* Able to speak and write English
* Able to hear and speak for phone interviews
* Owns a television
* Lives within 2 hours driving distance of recruitment site
Exclusion Criteria:
* Severe impairment of sight, hearing, speaking
* Active treatment for malignancy within past 3 months (other than non-melanoma skin cancer or long-term hormonal treatment for common cancers such as breast and prostate if disease is stable
* Weight greater than 330 pounds
* History of photosensitive seizures
* Any condition or disorder that would impede safe participation as directed
* Plans to relocate outside the area during the study period or unable to fully participate
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Cancer-related Fatigue Severity Using The Brief Fatigue Inventory.
Timeframe: about 6 weeks after discharge from the hospital
2
Cancer-Related Fatigue Fatigability as Assessed Using the 6 Minute Walk Test.
Timeframe: Immediately after discharge from the hospital